Skip to main content

Dave IncDE

For the period ended Dec 31, 2023. Filed Mar 5, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 5, 2024

DAVE$273.85-3.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of attorney (included on the signature page hereof)

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Joan Aristei or Kyle Beilman as his or her attorney-in-fact, with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or his substitute, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Jason WilkChief Executive Officer and Director(Principal Executive Officer)March 5, 2024
Jason Wilk
/s/ Kyle BeilmanChief Financial Officer(Principal Financial and Accounting Officer)March 5, 2024
Kyle Beilman
/s/ Brendan CarrollDirectorMarch 5, 2024
Brendan Carroll
/s/ Andrea MitchellDirectorMarch 5, 2024
Andrea Mitchell
/s/ Michael PopeDirectorMarch 5, 2024
Michael Pope
/s/ Dan PrestonDirectorMarch 5, 2024
Dan Preston
/s/ Imran KhanDirectorMarch 5, 2024
Imran Khan
/s/ Yadin RozovDirectorMarch 5, 2024
Yadin Rozov
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.